The equity fell 3.13 percent to touch Rs 1722.0, sliding past both its 20-day Simple Moving Average of 1763.35 and 20-day Exponential Moving Average of 1773.53. This decline deepens a medium-term pullback, with shares now down 11.16 percent over the trailing three months. By 09:18 AM IST, trading activity saw the price adjust slightly to Rs 1737.6 on a volume of 263,288 shares. The company maintains an earnings per share of 45.7 alongside a market capitalization of 426,529.78.
Key points
The breakdown below the 20-day moving averages signals continued short-term technical wea…: The breakdown below the 20-day moving averages signals continued short-term technical weakness for the stock.
Morning trading reversed the prior session's gain of 0.95 percent that had closed at Rs 1…: Morning trading reversed the prior session's gain of 0.95 percent that had closed at Rs 1761.0.
Financial indicators show the firm trading at a price-to-earnings ratio of 38.9 with a si…: Financial indicators show the firm trading at a price-to-earnings ratio of 38.9 with a six-month beta of 0.9173.
Sources checked by our analysis pipeline: 1
02 Nov 2026 | 09:18:38 AM IST
Sun Pharma share price live updates
Welcome to the Sun Pharma Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock. Stay ahead of the market with our in-depth coverage of Sun Pharma, including: Last traded price 1737.6, Market capitalization: 426529.78, Volume: 263288, Price-to-earnings ratio 38.9, Earnings per share 45.7. Get a complete picture of Sun Pharma's performance through our comprehensive blend of fundamental and technical indicators. Stay informed about breaking news that can influence the stock's trajectory. Our liveblog equips you with the knowledge and insights needed to make confident investment decisions. Don't miss out on the latest updates as Sun Pharma continues to make waves in the market. The data points are updated as on 09:18:38 AM IST, 02 Nov 2026
Show more Show less
1 New Update
09:18:31 AM IST, 02 Nov 2026
Sun Pharma Share Price Live Updates: Sun Pharma's Recent Price Drop Below EMA Signals a Shift
Sun Pharma has recently crossed below its 20-day Exponential Moving Average, currently priced at Rs 1722.0, reflecting…
Central bank officials are preparing the ground for tighter monetary policy as corporate price and wage behaviors increasingly align with institutional goals. Policymakers assessed that rate increases could curb persistent upside price pressures while ultimately safeguarding household purchasing power. This strategic shift hinges on labor productivity gains alongside corporate expectations steadily meeting the 2 percent threshold.
Strong operational execution drove second-quarter consolidated net profit to ₹169.66 crore, recovering sharply from ₹14.86 crore recorded in the prior-year period. The turnaround was propelled by growth across core textiles and flooring, leading major brokerages to issue upgraded price targets. Robust operational cash flow also successfully moved the manufacturer into a net cash positive financial position.
Ongoing geopolitical tensions involving the US-Iran conflict and the closure of the Strait of Hormuz have driven crude oil prices to elevated levels. Market analysts recommend pivoting capital toward upstream exploration and production firms to capitalize on surging international product spreads. This strategic shift favors producers over marketing companies due to substantial export income gains.